BusinessBeyondSpring Chief Medical Officer to Present Clinical Data for Lead Asset Plinabulin at 2017 BIO International Convention in San DiegoBy Nasdaq OMXJun 15, 2017, 1:03 PM UTC
BusinessNobilis Therapeutics’ NBTX-001 shows promise in treatment of patients with Panic DisorderBy Nasdaq OMXJun 14, 2017, 5:35 PM UTC
BusinessAbCellera Announces Expanded Research Collaboration with TevaBy Nasdaq OMXJun 13, 2017, 1:00 PM UTC
BusinessNobilis Therapeutics Receives a Notice of Allowance for a Patent Covering Treatment of Psychiatric Disorders With Noble GasesBy Nasdaq OMXJun 12, 2017, 10:58 PM UTC
BusinessBrainsway® Announces Positive Final Results of its Deep TMS Multicenter Study in Obsessive Compulsive Disorder (OCD) PatientsBy Nasdaq OMXJun 12, 2017, 4:35 PM UTC
BusinessAbeona Therapeutics Receives FDA Orphan Drug Designation for EB-101 Gene Therapy Product for Patients with Epidermolysis BullosaBy Nasdaq OMXMay 25, 2017, 12:10 PM UTC
BusinessAbeona Therapeutics Receives FDA Orphan Drug Designation for EB-101 Gene Therapy Product for Patients with Epidermolysis BullosaBy Nasdaq OMXMay 25, 2017, 12:10 PM UTC
BusinessAbeona Therapeutics Receives FDA Orphan Drug Designation for EB-101 Gene Therapy Product for Patients with Epidermolysis BullosaBy Nasdaq OMXMay 25, 2017, 12:10 PM UTC
